( Australia:QRX, OTC-PINK:QRXPY )

News from QRxPharma Limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

11 Jul, 2014, 09:00 ET QRxPharma Provides Feedback On End-of-Review Meeting With The FDA On Moxduo®

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) today provided feedback on its 9 July End-of-Review (EOR) meeting with the United States Food...


09 Jul, 2014, 09:02 ET QRxPharma Announces Board Resignations

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that Chairman, Dr. Peter Farrell and Director, Dr. Gary Pace have resigned from...


27 May, 2014, 06:00 ET QRxPharma Receives Complete Response Letter From FDA Regarding Moxduo® NDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug...


01 May, 2014, 22:00 ET Dr. Edward Rudnic Appointed CEO of QRxPharma

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that Dr. John Holaday has stepped down as Managing Director and Chief Executive...


24 Mar, 2014, 08:00 ET FDA Sets 22 April 2014 For Moxduo® Advisory Committee Meeting

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has set 22 April 2014 as...


13 Dec, 2013, 09:00 ET QRxPharma Completes A$11.6 Million Capital Raising

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) today announced the successful completion of its Share Purchase Plan (SPP) to existing...


11 Dec, 2013, 09:00 ET QRxPharma Announces 25 May 2014 as New PDUFA Date for MOXDUO® NDA

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Food and Drug Administration (FDA) has established 25 May...


26 Nov, 2013, 09:00 ET QRxPharma Refiles MOXDUO® New Drug Application with the FDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the Company resubmitted its MOXDUO® New Drug Application (NDA). At a...


13 Nov, 2013, 09:00 ET QRxPharma Announces Successful Completion Of A$7.5 Million Placement

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) ("QRxPharma") announced today the successful completion of a Placement to institutional and...


15 Oct, 2013, 09:00 ET QRxPharma Extends MOXDUO® License With Aspen

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the execution of a licensing agreement with Aspen Pharmacare Holdings Limited (JSE:...


09 Oct, 2013, 09:00 ET QRxPharma Reports Positive Meeting With The FDA On MOXDUO®

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the results of its meeting on October 3 with the United States Food and Drug...


11 Sep, 2013, 09:00 ET QRxPharma Announces MOXDUO® License With Aspen

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of a licensing agreement with Aspen Pharma Pty Ltd, one of the...


06 Sep, 2013, 09:00 ET FDA Schedules Review Meeting With QRxPharma Regarding MOXDUO® NDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has scheduled a meeting on 3...


22 Jul, 2013, 07:00 ET QRxPharma Announces Collaboration With Aesica

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of a Collaboration Agreement with Aesica Formulation Development Limited, a...


26 Jun, 2013, 09:14 ET QRxPharma Updates MOXDUO® NDA Review

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the planned 17 July 2013 US Food and Drug Administration (FDA) Advisory...


12 Jun, 2013, 09:00 ET QRxPharma Granted US Patent On Hybrid Opioids

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Patent and Trademark Office (USPTO) issued the...


17 May, 2013, 09:00 ET FDA Sets 17 July 2013 For MOXDUO® Advisory Committee Meeting

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the US Food and Drug Administration (FDA) has set 17 July 2013 as the date of...


14 Mar, 2013, 09:00 ET FDA Sets 26 August 2013 As New PDUFA Date For MOXDUO® NDA

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the US Food and Drug Administration (FDA) has set 26 August 2013 as the...


28 Feb, 2013, 09:00 ET QRxPharma Resubmits MOXDUO® New Drug Application to the FDA

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the Company resubmitted its MOXDUO® New Drug Application (NDA). As...


16 Jan, 2013, 08:00 ET QRxPharma and FDA Establish Path Forward for Resubmission Of MOXDUO® New Drug Application

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the steps necessary for approval of immediate release MOXDUO have been clarified...


23 May, 2012, 08:50 ET QRxPharma Granted Additional US Patent on MoxDuo®

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Patent and Trademark Office (USPTO) issued the Company U.S....


19 Mar, 2012, 08:50 ET QRxPharma Signs License and Option Agreement with Actavis

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of its License and Option Agreement (LOA) with Actavis, Inc. which...


08 Nov, 2011, 08:45 ET QRxPharma Granted Target Date for FDA Action on MoxDuo® IR NDA: NDA Accepted for Review; PDUFA Date Set for June 25, 2012

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today it received written acceptance from the United States Food and Drug Administration...


25 Aug, 2011, 08:05 ET QRxPharma Completes NDA Submission for MoxDuo® IR

Clinical Data Package to US FDA as Follow-Up to Initial CMC Filing QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today submission of...


25 Jul, 2011, 10:43 ET QRxPharma Announces A$35 Million Capital Raising to Progress MoxDuo Formulations and Support Commercialisation of MoxDuo® IR

Raise Also Strengthens Company Position For Partnering Negotiations QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) is pleased to announce the...